31 Results for "

small interfering RNA

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "small interfering RNA" in MCE Product Catalog:

9
9 Publications Verification
Art. -Nr.: HY-132591
CAS. Nr.: 1639324-58-5
Reinheit:  99.80%
Synonyms: ALN-PCSsc
Inclisiran is a double-stranded small interfering RNA (siRNA) molecule. Inclisiran inhibits the transcription of PCSK9. Inclisiran inhibits Pyroptosis, activates PPARγ, and reduces NLRP3, cleaved caspase-1, IL-1β, and IL-18. Inclisiran has anti-inflammatory, lipid-regulating and anti-atherosclerotic activities. Inclisiran can be used in researches of hyperlipidemia and cardiovascular disease (CVD) .
loading...
    loading...
9
9 Publications Verification
Art. -Nr.: HY-132591A
Reinheit:  98.10%
Synonyms: ALN-PCSsc sodium
Inclisiran sodium is a double-stranded small interfering RNA (siRNA) molecule. Inclisiran sodium inhibits the transcription of PCSK9. Inclisiran sodium inhibits Pyroptosis, activates PPARγ, and reduces NLRP3, cleaved caspase-1, IL-1β, and IL-18. Inclisiran sodium has anti-inflammatory, lipid-regulating and anti-atherosclerotic activities. Inclisiran sodium can be used in researches of hyperlipidemia and cardiovascular disease (CVD) .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-132589A
Reinheit:  96.37%
Synonyms: ALN-TTRsc02 sodium
Vutrisiran sodium (ALN-TTRsc02 sodium) is a liver-directed small interfering RNA (siRNA). Vutrisiran sodium targets the mRNA of transthyretin (TTR), and is applicable to studies on transthyretin (TTR)-mediated amyloidosis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-132609
CAS. Nr.: 1386913-72-9
Reinheit:  99.09%
Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-174228
CAS. Nr.: 552829-57-9
Forschungsgebiete:  

Cancer

I3IN-002 is a small-molecule RNA-binding protein IGF2BP3 inhibitor with an IC50 value of approximately 2 μM in SEM cells. I3IN-002 interferes with interaction with m6 A-modified mRNAs, disrupting the stabilization of target genes (such as CDK6, MYC, and BCL2) to inhibit leukemic cell growth, induce cell cycle arrest, and promote apoptosis. I3IN-002 is promising for research of B-cell acute lymphoblastic leukemia .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-132610
CAS. Nr.: 1639325-43-1
Reinheit:  98.51%
Synonyms: ALN-AS1
Forschungsgebiete:  

Metabolic Disease

Givosiran (ALN-AS1) is a small interfering RNA that targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA. Givosiran downregulates ALAS1 mRNA and prevents accumulation of neurotoxic δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) levels. Givosiran demonstrates potent inhibitory activity against ALAS1 in mouse, rat, and cynomolgus monkey models. Givosiran can be used for the research of acute hepatic porphyria (AHP) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-132610A
CAS. Nr.: 1639325-44-2
Reinheit:  98.51%
Synonyms: ALN-AS1 sodium
Forschungsgebiete:  

Metabolic Disease

Givosiran (ALN-AS1) sodium is a small interfering RNA that targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA. Givosiran sodium downregulates ALAS1 mRNA and prevents accumulation of neurotoxic δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) levels. Givosiran sodium demonstrates potent inhibitory activity against ALAS1 in mouse, rat, and cynomolgus monkey models. Givosiran sodium can be used for the research of acute hepatic porphyria (AHP) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-150223
Reinheit:  92.48%
Forschungsgebiete:  

Cardiovascular Disease

GalNAc unconjugated/naked Inclisiran is a double-stranded small interfering RNA molecule that targets hepatic PCSK9 production to reduce LDL-C levels. GalNAc unconjugated/naked Inclisiran can be used in the research of cardiovascular diseases and hypercholesterolemia .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-D1719A
Target:  

Fluorescent Dye

Forschungsgebiete:  

Cancer

Cypate is a near-infrared fluorescent dye that belongs to the family of photosensitizers. Cypate has high photostability and optical properties, and is often used in near-infrared optical imaging, as well as optical imaging, tumor marking, and drug delivery. In addition, Cypate is also used as a molecular probe and combined with targeting molecules (such as CBT or small interfering RNA) to achieve efficient detection and imaging of specific cells or tissues .
loading...
    loading...
Art. -Nr.: HY-143221
Reinheit:  95.13%
Target:  

Drug Intermediate

Forschungsgebiete:  

Cardiovascular Disease

AS-Inclisiran sodium is the antisense of Inclisiran (HY-132591). Inclisiran is a double-stranded small interfering RNA (siRNA) molecule. Inclisiran inhibits the transcription of PCSK9. Inclisiran inhibits Pyroptosis, activates PPARγ, and reduces NLRP3, cleaved caspase-1, IL-1β, and IL-18. Inclisiran has anti-inflammatory, lipid-regulating and anti-atherosclerotic activities. Inclisiran can be used in researches of hyperlipidemia and cardiovascular disease (CVD) .
loading...
    loading...
Art. -Nr.: HY-132596A
CAS. Nr.: 1848239-71-3
Reinheit:  96.85%
Synonyms: SYL1001 sodium
Tivanisiran sodium (SYL1001 sodium) is a small interfering RNA (siRNA) targeting TRPV1 . Tivanisiran sodium induces the degradation of TRPV1 mRNA, thereby inhibiting protein synthesis. Tivanisiran sodium alleviates ocular discomfort and pain, and improves ocular hyperemia and tear quality. Tivanisiran sodium is applicable to research related to dry eye disease .
loading...
    loading...
Art. -Nr.: HY-145638A
CAS. Nr.: 2538784-49-3
Reinheit:  95.90%
Synonyms: RO7445482 sodium
Target:  

HBV

Forschungsgebiete:  

Infection

Xalnesiran (RO7445482) sodium is a small interfering RNA molecule that targets a conserved region of the
hepatitis B virus (HBV) genome . Xalnesiran sodium can be used for the research of chronic hepatitis B infection .
loading...
    loading...
Art. -Nr.: HY-P10449
CAS. Nr.: 3098205-40-1
Target:  

Inhibitory Antibodies

Forschungsgebiete:  

Inflammation/Immunology Cancer

M2 Peptide is a peptide targeting M2-like tumor-associated macrophages (TAMs). M2 Peptide is used to carry drugs or small interfering RNA (siRNA) to promote the repolarization of M2-like macrophages to M1-like macrophages, thereby altering the immunosuppressive state in the tumor microenvironment and enhancing the anti-tumor immune response. M2 Peptide can be used to study the effect of macrophage polarization and how this polarization change affects tumor growth and metastasis .
loading...
    loading...
Art. -Nr.: HY-150224
Reinheit:  97.93%
Forschungsgebiete:  

Others

GalNAc unconjugated/naked Fitusiran (sodium), an small interfering RNA without GalNAc conjugation, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. Fitusiran increases thrombin generation and has the potential for the research of the hemophilia .
loading...
    loading...
Art. -Nr.: HY-153609
Reinheit:  92.51%
AS-Patisiran sodium is an antisense strand of Patisiran. Patisiran is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran can be used for the research of hereditary TTR amyloidosis .
loading...
    loading...
Art. -Nr.: HY-143220
Reinheit:  95.81%
SS (no Galnac)-Inclisiran sodium is the sense strand of Inclisiran (HY-132591) without GalNAc modification. Inclisiran is a double-stranded small interfering RNA (siRNA) molecule that inhibits the transcription of PCSK-9. SS (no Galnac)-Inclisiran sodium can be used in cardiovascular disease research .
loading...
    loading...
Art. -Nr.: HY-177640
CAS. Nr.: 2808361-18-2
Synonyms: LY3819469
Lepodisiran (LY3819469) is a GalNAc-conjugated small interfering RNA lipid-lowering agent. Lepodisiran targets the hepatic LPA gene and degrades apolipoprotein (a) mRNA to silence its expression, thereby effectively reducing the production of apolipoprotein (a) and serum lipoprotein (a) in a dose-dependent manner. Lepodisiran can be used in studies related to atherosclerotic cardiovascular disease .
loading...
    loading...
Art. -Nr.: HY-132595A
CAS. Nr.: 2169310-72-7
Reinheit:  90.25%
Synonyms: QPI-1002 sodium
Target:  

MDM-2/p53

Forschungsgebiete:  

Cancer

Teprasiran sodium is a small interfering RNA that temporarily inhibits p53-mediated cell death that underlies acute kidney injury (AKI) .
loading...
    loading...
Art. -Nr.: HY-132596
CAS. Nr.: 1848224-71-4
Reinheit:  92.62%
Synonyms: SYL1001
Tivanisiran (SYL1001) is a small interfering RNA (siRNA) targeting TRPV1 . Tivanisiran induces the degradation of TRPV1 mRNA, thereby inhibiting protein synthesis. Tivanisiran alleviates ocular discomfort and pain, and improves ocular hyperemia and tear quality. Tivanisiran is applicable to research related to dry eye disease .
loading...
    loading...
Art. -Nr.: HY-132595
CAS. Nr.: 1231737-88-4
Synonyms: QPI-1002
Forschungsgebiete:  

Cancer

Teprasiran (QPI-1002) is a small interfering RNA that temporarily inhibits p53-mediated cell death that underlies acute kidney injury (AKI) .
loading...
    loading...